In a move that has left tennis fans both concerned and curious, Alexander Zverev has withdrawn from the ABN AMRO Open in Rotterdam, citing ongoing ankle issues. But here's where it gets controversial: is this a wise decision to prioritize long-term health, or could it be seen as a missed opportunity to compete in a tournament he holds dear? Let’s dive into the details.
Alexander Zverev, the 24-time tour-level titlist and one of Germany’s most prominent tennis stars, announced his withdrawal from the Rotterdam tournament on Wednesday, February 4, 2026. The 28-year-old, who last competed in Rotterdam in 2023, expressed his disappointment in a statement. “I find it incredibly unfortunate that I have to make this decision,” Zverev said. “The ABN AMRO Open gave me a chance as a young player, and that’s why I always enjoy returning. However, given my history with my ankle, I have to prioritize my recovery and can’t take any risks. I wish everyone in Rotterdam a wonderful week.”
Zverev’s decision comes on the heels of a strong start to his 2026 season, which included a semi-final appearance at the Australian Open, where he lost a grueling five-set match to Carlos Alcaraz. According to the Infosys ATP Win/Loss Index, he holds a 6-2 record this year, making his withdrawal all the more surprising. And this is the part most people miss: Zverev’s recurring ankle problems have been a persistent issue, with his physio advising thorough recovery before he steps back onto the court.
Tournament director Richard Krajicek shared his thoughts on Zverev’s absence: “Given his history, we would naturally have liked to see Alexander back on court, but we also understand his decision here. Everyone still remembers the images and the impact of his previous ankle injury.” Krajicek’s words highlight the delicate balance between pushing through pain and safeguarding one’s career—a debate that often divides players, coaches, and fans alike.
Zverev’s withdrawal opens up opportunities for other top players at the ABN AMRO Open, which runs from February 9-16. The field includes Top 10 stars like Alex de Minaur, Felix Auger-Aliassime, and Alexander Bublik, ensuring that the tournament remains highly competitive despite Zverev’s absence.
But here’s the question that’s sparking debate: Is Zverev’s decision a smart move to prevent further injury, or does it risk slowing his momentum after a strong start to the season? Let us know your thoughts in the comments below. Wishing Zverev a smooth recovery, we’ll be eagerly awaiting his return to the court—hopefully stronger and healthier than ever.
